WHWKEarnings•prnewswire•
Whitehawk Therapeutics Reports Second Quarter 2025 Financial Results and Recent Highlights
Sentiment:Negative (30)
Summary
MORRISTOWN, N.J., Aug. 7, 2025 /PRNewswire/ -- Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved ADC cancer treatments, today announced financial results for the second...
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on August 7, 2025 by prnewswire